LX9211，缓解糖尿病性周围神经病理性疼痛的一颗新星。
LX9211, a rising star for relieving of diabetic peripheral neuropathic pain.
作者信息
Lee Chia-Chin, Ko Fu-Shun, Yen Fu-Shun, Hwu Chii-Min
机构信息
Section of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Dr. Yen's Clinic, Taoyuan, Taiwan.
出版信息
J Diabetes Investig. 2025 Feb;16(2):176-179. doi: 10.1111/jdi.14342. Epub 2024 Nov 7.
Abstract
In a multicenter trial, LX9211 significantly reduced pain in diabetic peripheral neuropathy (DPN) patients, with the 10 mg dose showing notable relief by the first week. Although the higher dose was less effective, side effects like dizziness and nausea were generally mild. These findings highlight the importance of exploring both pharmaceutical and natural treatments, such as flavonoids, for managing DPN.
摘要
在一项多中心试验中，LX9211显著减轻了糖尿病周围神经病变（DPN）患者的疼痛，10毫克剂量在第一周就显示出明显的缓解效果。尽管高剂量效果较差，但头晕和恶心等副作用通常较轻。这些发现凸显了探索药物治疗和天然治疗方法（如类黄酮）来管理DPN的重要性。
相似文献
1
LX9211, a rising star for relieving of diabetic peripheral neuropathic pain.LX9211，缓解糖尿病性周围神经病理性疼痛的一颗新星。
J Diabetes Investig. 2025 Feb;16(2):176-179. doi: 10.1111/jdi.14342. Epub 2024 Nov 7.
2
Efficacy and Safety of LX9211 for Relief of Diabetic Peripheral Neuropathic Pain (RELIEF-DPN 1): Results of a Double-Blind, Randomized, Placebo-Controlled, Proof-of-Concept Study.LX9211 治疗糖尿病周围神经性疼痛的疗效和安全性（RELIEF-DPN 1）：一项双盲、随机、安慰剂对照、概念验证研究的结果。
Diabetes Care. 2024 Aug 1;47(8):1325-1332. doi: 10.2337/dc24-0188.
3
Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.普瑞巴林治疗周围神经性疼痛：来自日本和西方的随机对照试验的安全性数据综述。
Drug Saf. 2012 Oct 1;35(10):793-806. doi: 10.2165/11632660-000000000-00000.
4
Oxcarbazepine for neuropathic pain.奥卡西平用于治疗神经性疼痛。
Cochrane Database Syst Rev. 2017 Dec 2;12(12):CD007963. doi: 10.1002/14651858.CD007963.pub3.
5
Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting.普瑞巴林与加巴喷丁治疗带状疱疹后神经痛和糖尿病性神经病变相关外周神经病理性疼痛的疗效比较：希腊医疗环境下的成本效益分析
BMC Neurol. 2013 Jun 4;13:56. doi: 10.1186/1471-2377-13-56.
6
Results of two Phase 1, Randomized, Double-blind, Placebo-controlled, Studies (Ascending Single-dose and Multiple-dose Studies) to Determine the Safety, Tolerability, and Pharmacokinetics of Orally Administered LX9211 in Healthy Participants.两项1期随机双盲安慰剂对照研究（单次递增剂量和多次递增剂量研究）的结果，以确定健康受试者口服LX9211的安全性、耐受性和药代动力学。
Clin Ther. 2021 Jun;43(6):1029-1050. doi: 10.1016/j.clinthera.2021.04.014. Epub 2021 Jun 6.
7
and gene modulation following pregabalin and duloxetine combination for painful diabetic polyneuropathy.以及普瑞巴林和度洛西汀联合治疗糖尿病性多发性神经病疼痛后的基因调节。
Pain Manag. 2024 Jun 2;14(5-6):273-281. doi: 10.1080/17581869.2024.2370758. Epub 2024 Jul 12.
8
Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy.乙酰左旋肉碱用于治疗糖尿病性周围神经病变。
Cochrane Database Syst Rev. 2019 Jun 15;6(6):CD011265. doi: 10.1002/14651858.CD011265.pub2.
9
An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain.一项纳入更多患者、随机撤药、剂量灵活、双盲、安慰剂对照、平行分组的研究，旨在评估纳布啡作为辅助药物治疗糖尿病周围神经性疼痛的疗效。
Pain. 2012 Oct;153(10):2073-2082. doi: 10.1016/j.pain.2012.06.024. Epub 2012 Aug 23.
10
Pharmacologic management of diabetic peripheral neuropathic pain.糖尿病周围神经性疼痛的药物治疗管理。
Expert Opin Pharmacother. 2013 Sep;14(13):1765-75. doi: 10.1517/14656566.2013.811490. Epub 2013 Jun 26.
本文引用的文献
1
Efficacy and Safety of LX9211 for Relief of Diabetic Peripheral Neuropathic Pain (RELIEF-DPN 1): Results of a Double-Blind, Randomized, Placebo-Controlled, Proof-of-Concept Study.LX9211 治疗糖尿病周围神经性疼痛的疗效和安全性（RELIEF-DPN 1）：一项双盲、随机、安慰剂对照、概念验证研究的结果。
Diabetes Care. 2024 Aug 1;47(8):1325-1332. doi: 10.2337/dc24-0188.
2
Biomarkers and signaling pathways of diabetic nephropathy and peripheral neuropathy: possible therapeutic intervention of rutin and quercetin.糖尿病肾病和周围神经病变的生物标志物及信号通路：芦丁和槲皮素可能的治疗干预
Diabetol Int. 2023 Dec 19;15(2):145-169. doi: 10.1007/s13340-023-00680-8. eCollection 2024 Apr.
3
Pharmacological Treatment of Diabetic Peripheral Neuropathy: An Update.糖尿病周围神经病变的药物治疗：最新进展
CNS Neurol Disord Drug Targets. 2022;21(10):884-900. doi: 10.2174/1871527320666210303111939.
4
Painful and Painless Diabetic Neuropathies: What Is the Difference?痛性和无痛性糖尿病周围神经病变：有何不同？
Curr Diab Rep. 2019 May 7;19(6):32. doi: 10.1007/s11892-019-1150-5.
5
Diabetic Neuropathy: A Position Statement by the American Diabetes Association.糖尿病神经病变：美国糖尿病协会的立场声明
Diabetes Care. 2017 Jan;40(1):136-154. doi: 10.2337/dc16-2042.
6
Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on Walking.普瑞巴林治疗疼痛性糖尿病周围神经病变及行走疼痛患者的疗效与安全性。
Clin J Pain. 2015 Nov;31(11):946-58. doi: 10.1097/AJP.0000000000000198.
7
A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: a randomized, double-blind, cross-over clinical trial.阿米替林与度洛西汀治疗糖尿病性神经痛的对比评价：一项随机、双盲、交叉临床试验。
Diabetes Care. 2011 Apr;34(4):818-22. doi: 10.2337/dc10-1793. Epub 2011 Feb 25.
8
A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.一项比较度洛西汀与安慰剂治疗糖尿病性周围神经病理性疼痛的双盲、随机多中心试验。
Pain Med. 2005 Sep-Oct;6(5):346-56. doi: 10.1111/j.1526-4637.2005.00061.x.
9
Duloxetine vs. placebo in patients with painful diabetic neuropathy.度洛西汀与安慰剂治疗糖尿病性疼痛性神经病变患者的对比研究
Pain. 2005 Jul;116(1-2):109-18. doi: 10.1016/j.pain.2005.03.029.
10
Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.普瑞巴林缓解糖尿病性疼痛性神经病变症状：一项随机对照试验。
Neurology. 2004 Dec 14;63(11):2104-10. doi: 10.1212/01.wnl.0000145767.36287.a1.
Zotero 插件